Challenges in Antibacterial Drug Development

2/25/02


Click here to start


Table of Contents

Challenges in Antibacterial Drug Development

Francis P. Tally M.D. Background

Challenges in Antibacterial Drug Development Characteristics of the Drug

Challenges in Antibacterial Drug Development

Challenges in Antibacterial Drug Development Characteristics to Justify Development

Challenges in Antibacterial Drug Development Classification of New Antibacterial Drugs

Challenges in Antibacterial Clinical Protocol Development

Challenges in Antibacterial Drug Development Trial Design

Bacterial Causes of Pneumonia

Challenges in Antibacterial Drug Development Trial Design

Challenges in Antibacterial Drug Development Challenges of Selecting Delta for Clinical Trial

Challenges in Antibacterial Drug Development “Biocreep”

Challenges in Antibacterial Drug Development Delta – Related to Efficacy Rates in 1992

Challenges in Antibacterial Drug Development Impact of Small Delta

Challenges in Antibacterial Drug Development Opinion

Challenges in Antibacterial Drug Development Opinion

Challenges in Antibacterial Drug Development Opinion

Challenges in Antibacterial Drug Development Problems With IV Only Drugs

Challenges in Antibacterial Drug Development Opinion – Paradox of Higher Mortality Infections

Challenges in Antibacterial Drug Development Overall Conclusions on Delta

Challenges in Antibacterial Drug Development Overall Conclusions on Delta

Author: Francis P. Tally M.D.